BridgeBio Pharma, Inc. (BBIO)

65.36 -0.81 (-1.22%) USD  |  NASDAQ  |  Mar 06, 16:00
65.32 -0.04 (-0.06%) After-Hours: 20:00
More

BridgeBio Pharma Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Insmed, Inc. --
Mirum Pharmaceuticals, Inc. Upgrade
Alphatec Holdings, Inc. --
Supernus Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade